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     Radiation therapy is considered as one of the main methods in cancer treatment. In this method, 
determination of exact location and geometric properties of tumor is necessary for treatment planning 
that leads to increased accuracy and output of treatment and reduction of healthy tissue dose. For this 
purpose, the aim of the present study has been physiological transmission of Gallium as a 
pharmaceutical carrier which is bonded with an X-Ray opaque media for treatment of Lymphatic tumor 
via Smart Radiotherapy method (Photoelectron therapy). Using radiography or CT scan has provided 
determination of geometric features of tumor.  
 




      The Radiation therapy is considered as one 
of the main methods in cancer treatment. In this 
method, determination of tumor location and its 
geometry is necessary for treatment planning. 
The time lapse in cancer patients causes a 
reduction of treatment prognosis in a way the 
chance of treatment comes close to zero. 
Unavailability of tumor geometric features leads 
to reduction of treatment precision and an 
increase in the normal tissue dose, leading to the 
reduction of treatment output, namely causing a 
decrease in the dose of tumor compared to the 
dose of normal tissue. Many efforts have been 
made around the world for cancer treatment and 
reducing the side effects of treatment methods. 
Drug carriers are substances that serve as 
mechanisms to improve the delivery and the 
effectiveness of drugs. So far, some drug 
carriers have been used in radiotherapy, 
chemotherapy and photodynamic therapy and 
also photoelectron therapy which have newly 
been proposed as a radiotherapy method with 
high efficiency; these are treatments via 
accumulation of a contrast media in tumor by a 
drug carrier. [1] The results of surveys have 
shown that drug carriers which are used in 
chemotherapy have increased the output up to 
45% [2] while the use of specific tumor marker 
in photoelectron therapy as a new method has 
shown the better results (increase output up to 
25 times). As a whole, considering the results 
that have been presented by researchers based 
on a significant increase of treatment output on 
laboratory animals and cultured cells at the 
presence of pharmaceutical substances with 
high atomic number, the necessity of synthesis 
of the proper pharmaceutical complex seems 
essential to the transmission the drugs with high 
atomic number into the tumors. [3] Chemical 
compounds are used in nuclear medicine for 
radionuclide transfer to the specific organs. 
Gallium is a pharmaceutical carrier which has 
been used in nuclear medicine for the purpose 
of transmission of radioisotope into the 
lymphatic tumor. The aim of this research has 
been to produce a pharmaceutical complex and 
study its physiological transmission into the 
lymphatic tumors for treatment via Smart 
Radiotherapy method (Photoelectron therapy). 
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We used Gallium as a pharmaceutical carrier 
which was bonded with Metrezoate as an X-Ray 
opaque media with high atomic number. [4] 
Implementation of this research aimed at 
identifying and analyzing effective factors in 
transferring metrezoate complex with gallium 
67 and 69 or special tumor markers for 
lymphatic tumors on cultured cells. Although 
gallium was more absorbed in tumors with 
lymphatic origin, large Cell lymphoma, Small 
cell Lymphoma and Bourkite cell Lymphoma 
were chosen, which multiplied in certain 
colonies with culture medium of gel. 
[5]Metrezoate complex and gallium 69   with 
concentrations of 50%, 60% and 75% were 
prepared in water and were added to these 
mediums. [6]Gallium in the periodic table of 
elements is placed [in the third main group and 
its characteristics is similar to trivalent 
aluminum. [7]Gallium69 and 67 were used as 
citrate with the same composition. Though 
gallium uptake is more in lymphatic tumors, 
Large Cell Lymphoma, Small cell Lymphoma 
and Bourkit Lymphoma are selected because 
they are malignant ones. These cells were 
proliferated in the certain colony in gel 
mediums. For testing, the colony number did 
not matter because the measuring of uptake 
volume percent in the cells was desired. [8] 
MATERIALS AND METHODS 
      Metrezoate complex and gallium 69 were 
prepared with concentrations of 50%, 60% and 
75% in water. Considering the X-ray, opaque 
agents were typically injected to target cell with 
volume content of 125% (permitted mean dose). 
In each test, ten of the same medium were 
prepared from each group of  aforementioned 
cell, half cubic centimeter of the complex were 
added to each medium in the manner that it was 
distributed in all medium surface. The 
experiment was repeated for each individual 
concentration. More accurately, the same 
procedure was repeated for each concentration 
in ten of other same mediums so that mean of 
ten measured concentrations for each cell and 
each group could be used. Then, in the intervals 
of 1, 2, 4, 8, 24, 48, 72 hours, the absorbed 
volume in the cells were measured. This volume 
follows the initial volume (one cubic 
centimeter) minus remained volume with cells 
in culture medium. The remaining volume was 
measured through minus medium volume and 
the left volume of complex solution; in some 
cases the remaining solution was sprayed with 
syringes. While temperature, humidity, all of 
physical conditions and type of culture medium 
for all samples were the same, it has been 
expected that the remaining or absorbed volume 
in culture medium to have no significant 
difference. Even for the three cell types that 
were examined, these amounts were very close 
to each other. Table [1] lists the values of ten 
times testing and measuring for each of three 
cell types at different time intervals. Since the 
measurements of remained volume for 
determining exact time of maximum 
accumulation of markers in the cell colony was 
not sufficient, gallium scan test from culture 
medium at intervals of 1, 4, 24 and 72 hours 
were carried out. At first, marker solution in 
which gallium 67 was used was added in the 
form of physiological serum with specific 
activity of 50 MicroCi in five drops to the 
gelatin medium. The utilized process was 
determined based on normal prescription of 
gallium 67 to average content of 10 mCi for 
tumors with approximate mass of 50 gr. Culture 
bed scanning after adding gallium 67dispalyed 
the image without proper contrast or resolution 
which proved to be useless. For this reason, 
after adding the solution at aforementioned time 
intervals before scanning each by gama camera, 
culture medium was rinsed by physiological 
serum solution until the amount of specific 
activity of gallium became visible. 
RESULTS 
   Results of tests on the lymph cells are shown 
in Table (1). A comparison of initial volume 
(one cubic centimeter) and residual volume at 
different time intervals showed that the total 
volume was not equal to absorbed volume in the 
cells plus the residual volume,  as it absorbs 
some solutions in the culture medium, and this 
medium  was the same for all cultures;  
consequently the different concentration (three 
type of concentration) did not have a significant 
effect on absorption percentage, yet more 
concentration caused more effective atomic 
number. Absorbed volume of field was 
determined using medium without cells. Cell 
test Results manifested that physicochemical 
property of gallium complex was similar to 
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gallium itself. Gallium played the role of carrier 
in this collection. The maximum amount of 
complex which was added to culture medium 




cells and consequently effective atomic number 
of these cells achieved 20% more than adjacent 
cells. This process provides planning for 
treatment with new radiation therapy technique 
that has been the ultimate goal of this drug 
complex.Density of neoplasm’s cell colony with 
lymphoid origin can be seen in scan images of 
Gallium 67 (Figure 1 to 4). This figure showed 
that the marker accumulation in the cell culture 
medium reaches a maximum  after 4 hours. 
Colony activity measurement showed the 
following values: Diameter containers for 
neoplasm cultured colonies were 10 cm. 
1 - 1-hour samples: 16 mCi: about 21 440 Kant. 
2 - 4-hour samples: 29 mCi: about 36 250 Kant. 
3 - 24-hour samples: 23 mCi: about 27 600 Kant 
.4 - 72-hour samples: 20 mCi: about 26 400 
Kant Demonstrated.  
 
 
Figure 1. Image Scan of culture cells with lymphoid 
neoplasm origin with the marker solution of gallium 67, 
using a gamma camera hours after adding the solution 
  
Figure  2. Image scan cell culture origin lymphoid 
neoplasm associated with a marker solution of gallium 67 




Figure  3.  Image scan cell culture origin lymphoid 
neoplasm associated with a marker solution of gallium 67 
using gamma camera 24 h after adding solution using 
Gallium metrozoate complex 




































Table 1.  residual volume values of complex markers (not absorbed) 








Figur 4. Image scan cell culture origin lymphoid neoplasm 
associated with a marker solution of gallium 67 using 
gamma camera 72 h after adding solution 
 
Summary of final Results are as follows:  
     1. It's better to use drug complex of gallium 
with Metrezoate in highest concentration of 
75%.2. Proper time for designing new treatment 
was between 24 to 48 hours after injection.3. 
With a simple X-ray radiography more accurate 
time for each specific patient can be determined 
after 24 hours. 
 
DISCUSSION 
     A research was conducted in oncology 
department of Minnesota University and the 
results were published in 2001. Since gallium  
absorption is more in neoplasm cells (about 40% 
higher than the average rate of other cells) and 
this property was more within lymphatic cells, 
result of using this complex on patients 
increased the efficiency to 45%. [8,9] Our 
calculation in the present study, which is in line 
with the findings of the aforementioned 
research, shows the efficiency increase to more 
than two thousand percent. [9,10]   
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